Octreotide therapy of growth hormone excess in the McCune-Albright syndrome

S. I. Sherman, Paul W Ladenson

Research output: Contribution to journalArticle

Abstract

We report a patient with the McCune-Albright syndrome and growth hormone excess. Biochemical evaluation demonstrated characteristic changes typical of acromegaly, and an unusual pattern of delayed somatotropin response to hGHRH40, not previously described in this syndrome. Therapeutic trial of low-dose octreotide successfully reversed his growth hormone excess, whereas bromocriptine failed to reduce growth hormone levels. Previous reports of acromegaly and McCune-Albright syndrome are reviewed, and the unique features of this case discussed

Original languageEnglish (US)
Pages (from-to)185-190
Number of pages6
JournalJournal of Endocrinological Investigation
Volume15
Issue number3
DOIs
StatePublished - 1992

Fingerprint

Polyostotic Fibrous Dysplasia
Acromegaly
Octreotide
Growth Hormone
Bromocriptine
Therapeutics
Growth hormone excess

Keywords

  • acromegaly
  • McCune-Albright syndrome
  • octreotide

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Octreotide therapy of growth hormone excess in the McCune-Albright syndrome. / Sherman, S. I.; Ladenson, Paul W.

In: Journal of Endocrinological Investigation, Vol. 15, No. 3, 1992, p. 185-190.

Research output: Contribution to journalArticle

@article{f890b9fc7acb4887a4bdc7550cc991a7,
title = "Octreotide therapy of growth hormone excess in the McCune-Albright syndrome",
abstract = "We report a patient with the McCune-Albright syndrome and growth hormone excess. Biochemical evaluation demonstrated characteristic changes typical of acromegaly, and an unusual pattern of delayed somatotropin response to hGHRH40, not previously described in this syndrome. Therapeutic trial of low-dose octreotide successfully reversed his growth hormone excess, whereas bromocriptine failed to reduce growth hormone levels. Previous reports of acromegaly and McCune-Albright syndrome are reviewed, and the unique features of this case discussed",
keywords = "acromegaly, McCune-Albright syndrome, octreotide",
author = "Sherman, {S. I.} and Ladenson, {Paul W}",
year = "1992",
doi = "10.1007/BF03348702",
language = "English (US)",
volume = "15",
pages = "185--190",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Editrice Kurtis s.r.l.",
number = "3",

}

TY - JOUR

T1 - Octreotide therapy of growth hormone excess in the McCune-Albright syndrome

AU - Sherman, S. I.

AU - Ladenson, Paul W

PY - 1992

Y1 - 1992

N2 - We report a patient with the McCune-Albright syndrome and growth hormone excess. Biochemical evaluation demonstrated characteristic changes typical of acromegaly, and an unusual pattern of delayed somatotropin response to hGHRH40, not previously described in this syndrome. Therapeutic trial of low-dose octreotide successfully reversed his growth hormone excess, whereas bromocriptine failed to reduce growth hormone levels. Previous reports of acromegaly and McCune-Albright syndrome are reviewed, and the unique features of this case discussed

AB - We report a patient with the McCune-Albright syndrome and growth hormone excess. Biochemical evaluation demonstrated characteristic changes typical of acromegaly, and an unusual pattern of delayed somatotropin response to hGHRH40, not previously described in this syndrome. Therapeutic trial of low-dose octreotide successfully reversed his growth hormone excess, whereas bromocriptine failed to reduce growth hormone levels. Previous reports of acromegaly and McCune-Albright syndrome are reviewed, and the unique features of this case discussed

KW - acromegaly

KW - McCune-Albright syndrome

KW - octreotide

UR - http://www.scopus.com/inward/record.url?scp=0026633436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026633436&partnerID=8YFLogxK

U2 - 10.1007/BF03348702

DO - 10.1007/BF03348702

M3 - Article

C2 - 1624678

AN - SCOPUS:0026633436

VL - 15

SP - 185

EP - 190

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 3

ER -